Realizing benefit sharing - the case of post-study obligations

Bioethics

Volumn 26, Issue 6, 2012, Pages 305-314

  Schroeder, Doris ^a   Gefenas, Eugenijus ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Benefit sharing; Human genetics; International justice; International research ethics; Post study obligations

Indexed keywords

EID: 84862628429     PISSN: 02699702     EISSN: 14678519     Source Type: Journal    
DOI: 10.1111/j.1467-8519.2010.01857.x     Document Type: Article

References (53)

1. Conflict of interest statement: No conflicts declared
2. Source:Modified from A. Nyika etal., 2009.
3. A.L. Caplan & D.R. Curry Leveraging Genetic Resources or Moral Blackmail? Indonesia and Avian Flu Virus Sample Sharing. Am J Bioeth 2007; 7 (11): 1-2.
4. E.R. Sedyaningsih at al. Towards Mutual Trust, Transparency and Equity in Virus Sharing Mechanism: The Avian Influenza Case of Indonesia. Ann Acad Med Singapore 2008; 37(6): 482-488, p. 487 (our emphasis).
5. D. Schroeder Benefit Sharing - High Time for a Definition. J Med Ethics 2007; 33: 205-209; D. Schroeder & T. Pogge Justice and the Convention on Biological Diversity. Ethics Int Aff 2009; 23: 265-278.
6. United Nations. Convention on Biological Diversity. Preamble. Rio de Janeiro, 5 June 1992. Available at: [Accessed 16 Dec 2009].
7. D.P. Fidler Influenza Virus Samples, International Law, and Global Health Diplomacy. Emerg Infect Dis 2008; 14(1): 88-94.
8. Convention on Biological Diversitry (CBD). 2005. Decision II/11. Access to Genetic Resources. Montreal: UNEP/CBD: paragraph 2. '[The Conference of the Parties][r]eaffirms that human genetic resources are not included within the framework of the Convention.'
9. S. Chaturvedi at al. Concentric Circles of the Benefit Sharing Debate and Disconnects with Technology: Challenges for a Global ABS Regime. Unpublished manuscript presented at: Genomics and Benefit Sharing with Developing Countries - from Biodiversity to Human Genomics 6 November 2009; Hilton, Montreal, Canada.
10. W. Falcon & C. Fowler Carving up the Commons - Emergence of a New International Regime for Germplasm Development and Transfer. Food Policy 2002; 27: 197-222.
11. S. Laird & R. Wynberg. 2008. Access and Benefit-sharing in Practice: Trends in Partnerships across Sectors. CBD Technical Series: 122-128
12. B. Visser, etal. 2005. Options for Non-Monetary Benefit-Sharing: an inventory. Rome: FAO
13. See Box 1, Articles 14 and 33 of Helsinki.
14. Z. Zhiyong Should Post-trial Provision of Beneficial Experimental Interventions be Mandatory in Developing Countries? J Med Ethics 2008; 34: 188-192.
15. World Medical Association (WMA). 2008. Declaration of Helsinki. Seoul, October 2008. Available at: [Accessed 16 Dec 2009]. We assume with Udo Schuklenk that the Declaration of Helsinki has the most reasonable claim to be taken seriously world-wide and shall therefore restrict references to guidelines to the Declaration. When comparing the Declaration of Helsinki with other influential guidelines, Schuklenk writes: 'an international consensus among smallish operators with impressive names is not a sufficient reason to do away with the authority of the WMA, which represents more members of the medical profession in one single country, let alone across the world, than the rest of the organisations and institutions mentioned...combined.' See U. Schuklenk The standard of care debate: against the myth of an 'international consensus opinion'. J Med Ethics 2004; 30: 194-197.
16. See, for instance, and D. Schroeder Post-Trial Obligations. Reciis 2008; 2 (Sup1) Sup 63-73.
17. D. N. Shaffer etal. Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinical researchers, and administrators in western Kenya. Journal of Medical Ethics 2006; 32: 55-60, p55.
18. Barack Obama's new health care bill might bring the US system in line with European welfare state systems.
19. See for a more detailed discussion D. Schroeder Double Standards and Benefit Sharing. Monash Bioeth Rev 2008; 27(4): 45-51.
20. E.J. Emanuel etal. What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research. J Infect Dis 2004; 189: 930-937; K. Leisinger Corporate Responsibilities for Access to Medicines. J Bus Ethics 2009; 85: 3-23; Nuffield Council on Bioethics. 2002. The Ethics of Research Related to Healthcare in Developing Countries. Available at: [Accessed 30 Apr 2010].
21. K. Leisinger Corporate Responsibilities for Access to Medicines. J Bus Ethics 2009; 85: 3-23
22. Nuffield Council on Bioethics. 2002. The Ethics of Research Related to Healthcare in Developing Countries. Available at: [Accessed 30 Apr 2010]
23. United Nations. 1948. The Universal Declaration of Human Rights. Paris. 10 December 1948. Available at: [Accessed 25 Nov 2009].
24. United Nations. 1966. International Covenant on Economic, Social and Cultural Rights. 16 December 1966. Available at: [Accessed 25 Nov 2009].
25. United Nations. 1979. Convention on the Elimination of All Forms of Discrimination against Women. 18 December 1979. Available at: [Accessed 25 Nov2009].
26. United Nations. 1989. Convention on the Rights of the Child. 20 November 1989. Available at: [Accessed 25 Nov 2009].
27. United Nations. 1978. Declaration of Alma-Ata. Alma-Ata. 6-12 September 1978. Available at: [Accessed 25 Nov 2009].
28. United Nations Committee on Economic, Social and Cultural Rights. 2000. Substantive Issues Arising in the Implementation of the International Covenant on Economic, Social and Cultural Rights. General Comment No. 14 (2000). Geneva, 25 April-12 May 2000. Available at: [Accessed 25 Nov 2009].
29. United Nations. 2000. Millennium Development Goals. Available at: [Accessed 25 Nov 2009].
30. A. Grover. 2009. Promotion and Protection of all Human Rights, Civil, Political, Economic, Social and Cultural Rights, including the Right to Development, a Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. United Nations, A/HRC/11/12, pp. 6, 7, 28.
31. This is not the space to detail justice issues within the international economic order and make a case for their avoidability. This has been done excellently elsewhere, see T. Pogge. 2008. World Poverty and Human Rights. 2nd edn. Cambridge: Polity Press; P. Singer. 2009. The Life You Can Save. London: Picador; J. Sachs. 2005. The End of Poverty. London: Penguin Books.
32. For more information on the case, see P. Andanda Vulnerability: Sex Workers in Nairobi's Majengo. Cambridge Quarterly of Healthcare Ethics 2009; 18: 138-146.
33. J. Kimmelman, C. Weijer & E.M. Meslin Helsinki Discords: FDA, Ethics, and International Drug Trials. Lancet 2009; 373: 13-14.
34. R. Macklin. 2004. Double Standards in Medical Research in Developing Countries. Cambridge: Cambridge University Press: 84.
35. Due to space constraints, we cannot discuss potential differences between sponsors and funders in this context.
36. National Health Council. 1997. Resolution No 251. 7 August 1997. Available at: [Accessed 25 Mar 2007].
37. C.A. Schuppli & D. Fraser Factors influencing the effectiveness of research ethics committees. J Med Ethics 2007; 33: 294-301.
38. A. Nyika etal. Composition, Training Needs and Independence of Ethics Review Committees across Africa: Are the Gate-keepers Rising to the Emerging Challenge? J Med Ethics 2009; 35: 189-193, p. 193.
39. A.A. Hyder etal. Ethical Review of Health Research: a Perspective from Developing Country Researchers. J Med Ethics 2004; 30: 68-72.
40. Trade and Industry Committee of Parliament of United Kingdom. 2002. TradeandIndustry - Twelfth Report. Available at: [Accessed 24 Oct 2009].
41. D. Lowe. 2004. Drug Development: The Current Odds. Corante. Available at: [Accessed 24 Oct 2009].
42. B. Brody Ethical Issues in Clinical Trials in Developing Countries. Stat Med 2002; 21: 2853-2858; J.R. McMillan & C. Conlon The Ethics of Research Related to Health Care in Developing Countries. J Med Ethics. 2004; 30: 204-206.
43. K. Shapiro & S.R. Benatar HIV Prevention Research and Global Inequality: Steps Towards Improved Standard of Care. J Med Ethics 2005; 31: 39-47, p. 42.
44. Of course, one could argue that comprehensive health care during a study is too little in terms of benefit sharing. However, if comprehensive health care is offered to study participants and their families, sometimes over decades, as may be the case for some Nairobi sex workers, this claim seems dubious.
45. UNESCO. 2005. Universal Declaration on Bioethics and Human Rights. 19 October 2005. Available at: [Accessed 24 Oct 2009].
46. Council for International Organizations of Medical Sciences (CIOMS). 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva. 2002. Available at: [Accessed 9 Apr 2009].
47. C. Pace & E. Emanuel The Ethics of Research in Developing Countries: Assessing Voluntariness. Lancet 2005; 365: 11-12.
48. G. J. Annas & M. A. Grodin Human Rights and Maternal-fetal HIV Transmission Prevention Trials in Africa. Am J Public Health 1998; 88: 560-563.
49. A. Ballantyne Benefits to Research Subjects in International Trials: Do They Reduce Exploitation or Increase Undue Inducement? Dev World Bioeth 2008; 8(3): 178-191.
50. Z.A. Bhutta. 2004. Building Capacity for Ethical Review in Developing Countries. SciDevNet 1 June. Available at: [Accessed 9 Apr 2009].
51. B.M. Knoppers. Editorial. Genetic Benefit Sharing. Science 2000; 290(5489); K. Berg & R. Chadwick Solidarity and Equity: New Ethical Frameworks for Genetic Databases. Nature Reviews 2001; 2: 318-321.
52. CIOMS, op. cit. note 45.
53. Grover, op. cit. note 29.